Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury

NCT03139682 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT03139682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03139682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury
Lead sponsor
Nova Scotia Health Authority
Phase
Observational
Overall status
Completed
Start date
August 3, 2017
Completion date
August 3, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood brain barrier defect, traumatic brain injury